Skip to content

Press Releases

Haemonetics Announces CE Mark Certification for the VASCADE MVP® XL Venous Vascular Closure System

Nov 18, 2026

Haemonetics Corporation Announces Second Quarter Fiscal 2027 Financial Results Available on Investor Relations Website

Nov 05, 2026

Haemonetics Announces FDA Approval of PerQseal® Elite Vascular Closure System

Oct 19, 2026

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2027 Results: November 5, 2026

Sep 30, 2026

Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website

Aug 06, 2026

New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths

Aug 03, 2026

Martin Madaus Elected to Haemonetics Board of Directors

Jul 28, 2026

Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2027 Results: August 6, 2026

Jul 08, 2026

Haemonetics Updates Financial Reporting Segments

Jun 05, 2026

Haemonetics to Present at Goldman Sachs 47th Annual Global Healthcare Conference

Jun 02, 2026

Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

May 07, 2026

Haemonetics to Present at Bank of America 2026 Healthcare Conference

May 05, 2026